Non-Small Cell Lung Cancer Archives - Page 47 of 49 - Cancer Therapy Advisor

Non-Small Cell Lung Cancer

Gilotrif May Improve Overall Survival in Lung Cancer

Gilotrif May Improve OS in Lung Cancer

Boehringer Ingelheim announced new overall survival data from two Phase 3 trials, LUX-Lung 3 and LUX-Lung 6 for Gilotrif (afatinib) in patients with advanced NSCLC whose tumors have a EGFR mutation.

Mechanisms of Tyrosine Kinase Inhibitor Resistance in Lung Cancer

Necitumumab Effective for NSCLC

Eli Lilly and Company announced results from the largest Phase 3 SQUIRE trial of necitumumab for the first-line treatment of squamous non-small cell lung cancer (NSCLC).

Will Biologics Ever Be the Standard of Care for Lung Cancer?

Results Announced for Ganetespib in NSCLC Trial

Synta Pharmaceuticals announced final results from the GALAXY-1 trial for ganetespib in patients with advanced non-small lung cancer (NSCLC) with adenocarcinoma histology most likely to benefit from second-line treatment.

Next post in Lung Cancer